A biologist's perspective on malaria vaccine development

Human Vaccines

Volumn 6, Issue 1, 2010, Pages

  Sinden, R E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell biology; Malaria biology; Models; Population dynamics; Vaccine

Indexed keywords

MALARIA VACCINE; DNA VACCINE; LIVE VACCINE; RECOMBINANT VACCINE; SUBUNIT VACCINE;

ANOPHELES STEPHENSI; DRUG RESEARCH; ERADICATION THERAPY; ERYTHROCYTE; GAMETOCYTE; HOST PARASITE INTERACTION; HUMAN; MALARIA; MORBIDITY; MORTALITY; NONHUMAN; OOCYST; PARASITE TRANSMISSION; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; POPULATION RISK; PROFESSIONAL KNOWLEDGE; PROTEIN EXPRESSION; REVIEW; SPOROZOITE; DISEASE TRANSMISSION; GENETICS; HISTORY; IMMUNOLOGY; PLASMODIUM;

DISEASE TRANSMISSION, INFECTIOUS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALARIA; MALARIA VACCINES; PLASMODIUM; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 74949101623     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.1.9604     Document Type: Review

References (74)

1. Cox-Singh J, Singh B. Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol 2008; 24:406-10.
2. Kreier JP. Editor Malaria Vol. 3 Immunology and Immunization. Academic Press, New York 1980.
3. Graves PM, Gelband H. Vaccines for preventing malaria (SPf66). Cochrane Database of Systematic Reviews 2006; 2: Art No.: CD005966. DOI: 10.1002/14651858.CD005966.
4. Graves PM, Gelband H. Vaccines for preventing malaria (pre-erythrocytic). Cochrane Database of Systematic Reviews 2006; 2: Art No.: CD006198. DOI: 10.1002/14651858.CD006198.
5. Graves PM, Gelband H. Vaccines for preventing malaria (blood-stage). Cochrane Database of Systematic Reviews 2006; 4: Art No.: CD006199. DOI: 10.1002/14651858.CD006199.
6. Miller LH. Current Prospects and Problems for a Malaria Vaccine. Journal of Infectious Diseases 1977; 135:855-64.
7. Amino R, Thiberge S, Martin B, Celli S, Shorte S, Frischknecht F, Ménard R. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nature Medicine 2006; 12:220-4.
8. Kebaier C, Voza T, Vanderberg J. Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog 2009; 5:1000399.
9. Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz JF, et al. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 2008; 3:88-96.
10. Vanderberg JP, Frevert U. Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol 2004; 34:991-6.
11. Sinden RE, Smith JE. The role of the Kupffer cell in the infection of rodents by the sporozoites of Plasmodium yoelii nigeriensis: studies in vivo and in perfused livers. Acta Tropica 1982; 39:11-27.
12. Baer K, Roosevelt M, Clarkson AB Jr, van Rooijen N, Schneider T, Frevert U. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver. Cellular Microbiology 2007; 9:397-412.
13. Smith JE, Alexander J. Evasion of macrophage microbicidal mechanisms by mature sporozoites of Plasmodium yoelii yoelii. Parasitology 1986; 93:33-8.
14. Usynin I, Klotz C, Frevert U. Malaria circumsporozoite protein inhibits the respiratory burst in Kupffer cells. Cell Microbiol 2007; 9:2610-28.
15. Ishino T, Chinzei Y, Yuda M. A Plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection. Cell Microbiol 2005; 7:199-208.
16. Suhrbier A, Castellano E, Sinden RE. Survival and antigenic profile of the irradiated sporozoite in the infected liver cell. Infection and Immunity 1990; 58:2834-9.
17. Albuquerque SS, Carret C, Grosso AR, Tarun AS, Peng X, Kappe SH, et al. Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics 2009; 10:270. doi: 10.1186/1471-2164-10-270.
18. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. PNAS 2008; 105:305-10.
19. Doolan DL, Aguiar JC, Weiss WR, Sette A, Felgner PL, Regis DP, et al. Utilization of genomic sequence information to develop malaria vaccines. J Exp Biol 2003; 206:3789-802.
20. Terzakis JA, Vanderberg JP, Foley D, Shustak S. Exoerythrocytic merozoites of Plasmodium berghei in rat hepatic Kupffer cells. J Protozool 1979; 26:385-9.
21. Baer K, Klotz C, Kappe SH, Schnieder T, Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 2007; 3:171.
22. Cohen S, McGregor IA, Carrington S. Gammaglobulin and acquired immunity in human malaria. Nature 1961; 192:733-7.
23. Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL, Collins FH, Duffy PE. Malaria: progress, perils and prospects for eradication. J Clin Invest 2008; 118:1266-76.
24. Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun 2004; 72:1557-67.
25. Chitnis CE, Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol 2008; 24:29-34.
26. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998; 4:358-60.
27. Duffy PE. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology 2007; 134:1877-81.
28. Sutherland CJ. Surface antigens of Plasmodium falciparum gametocytes - A new class of transmission-blocking vaccine targets? Mol Biochem Parasitol 2009; 166:93-8.
29. Sinden RE, Butcher GA, Billker O, Fleck S. Regulation of infectivity of Plasmodium to the mosquito vector. Adv Parasitol 1996; 38:53-117.
30. Motard A, Baccam D, Landau I. Temporary Loss of Plasmodium Gametocytes Infectivity during Schizogony. Ann Parasitol Hum Comp 1990; 65:218-20.
31. Naotunne TD, Karunaweera ND, Mendis KN, Carter R. Cytokine-Mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 1993; 78:555-62.
32. Butcher GA. Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 1997; 27:975-87.
33. Aponte JJ, Aide P, Renom M, Mandomando I, Bassat Q, Sacarlal J, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007; 370:1543-51.
34. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Aide P, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005; 366:2012-8.
35. Graves PM, Carter R, Burkot T, Quakyi IA, Kumar N. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunology 1988; 10:209-18.
36. Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, Vandruten J, et al. A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule- specific competition enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1995; 52:60-5.
37. Mair G, Braks JAM, Garver LS, Wiegant JCAG, Hall N, Dirks RW, et al. Regulation of sexual development of Plasmodium by translational repression. Science 2006; 313:667-9.
38. Billker O, Lindo V, Panico M, Etienne AE, Paxton T, Dell A, et al. Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature 1998; 392:289-92.
39. Ranawaka G, Alejo-Blanco A, Sinden RE. Characterization of the effector mechanisms of a transmission-blocking antibody upon differentiation of Plasmodium berghei gametocytes into ookinetes in vitro. Parasitology 1994; 109:11-7.
40. Simonetti AB, Billingsley PF, Winger LA, Sinden RE. Kinetics of expression of two major Plasmodium berghei antigens in the mosquito vector Anopheles stephensi. J Eukaryot Microbiol 1993; 40:569-76.
41. Lensen AHW, Vangemert GJA, Bolmer MG, Meis JFGM, Kaslow D, Meuwissen JHET, Ponnudurai T. Transmission blocking antibody of the Plasmodium falciparum zygote/ookinete surface protein pfs25 also influences sporozoite development. Parasite Immunol 1992; 14:471-9.
42. Ranawaka G, Alejo-Blanco R, Sinden RE. The effect of transmission- blocking antibody ingested in primary and secondary bloodfeeds, upon the development of Plasmodium berghei in the mosquito vector. Parasitology 1993; 107:225-31.
43. Outchkourov NS, Roeffen W, Kaan A, Jansen J, Luty A, Schuiffel D, et al. Correctly folded pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. PNAS 2008; 105:4301-5.
44. Williamson KC, Keister DB, Muratova O, Kaslow DC. Recombinant pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol Biochem Parasitol 1995; 75:33-42.
45. Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 2005; 23:3131-8.
46. Gozar MMG, Price VL, Kaslow DC. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice. Infection and Immunity 1998; 66:59-64.
47. Liu Y, Tewari R, Ning J, Blagborough AM, Garbom S, Pei J, et al. The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes. Genes Dev 2008; 22:1051-68.
48. Lal K, Prieto JH, Bromley E, Sanderson SJ, Yates JR, 3rd, Wastling JM, et al. Characterisation of Plasmodium invasive organelles; an ookinete microneme proteome. Proteomics 2009; 9:1142-51.
49. Grotendorst CA, Carter R. Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes II. changes in sensitivity to complement-like factors during zygote development. J Parasitol 1987; 73:980-4.
50. Margos G, Navarette S, Butcher G, Davies A, Willers C, Sinden RE, Lachmann PJ. Interaction between host complement and mosquito-midgut-stage Plasmodium berghei. Infect Immun 2001; 69:5064-71.
51. Sinden RE, Smalley MJ. Gametocytes of Plasmodium falciparum: phagocytosis by leucocytes in vivo and in vitro. Trans Roy Soc Trop Hyg Med 1976; 70:344-45.
52. Fallon MJM. The immuno-identification of the bloodmeals of erythrophagous arthropods. Ph.D. thesis Imperial College London 1987.
53. Han YS, Thompson J, Kafatos FC, Barillas-Mury C. Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes. EMBO J 2000; 19:6030-40.
54. Vaughan J, Do Rosario V, Leland P, Adjepong A, Light J, Woolet GR, et al. Plasmodium falciparum: ingested antisporozoite antibodies affect sporogony in Anopheles stephensi mosquitoes. Exptl Parasitol 1988; 66:171-82.
55. Yoshida S, Ioka D, Matsuoka H, Endo H, Ishii A. Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes. Mol Biochem Parasitol 2001; 113:89-96.
56. de Lara Cupurro M, Coleman J, Beerntsen BT, Myles KM, Olson KE, Rocha E, et al. Virus-expressed, recombinant single-chain antibody blocks sporozoite infection of salivary glands in Plasmodium gallinaceum-infected Aedes aegypti. Am J Trop Med Hyg 2000; 62:427-32.
57. Lal AA, Patterson PS, Sacci JB, Vaughan JA, Paul C, Collins WE, et al. Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. PNAS 2001; 98:5228-33.
58. Willadsen P. Anti-tick vaccines. Parasitology 2004; 12:367-87.
59. Dinglasan RR, Kalume DE, Kanzok SM, Ghosh AK, Muratova O, Pandey A, Jacobs-Lorena M. Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen. PNAS 2007; 104:13461-6.
60. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967; 216:160-2.
61. Cochrane AH, Nussenzweig RS, Nardin EH. Immunization against sporozoites, in Malaria vol. 3 Immunology and Immunization. Kreier JP, Ed. Academic Pres, New York 1980; 163-202.
62. Huff CG, Marchbank DF, Shiroishi T. Changes in Infectiousness of malaria gametocytes II. Analysis of the possible causative factors. Exptl Parasitol 1958; 7:399-417.
63. Vanderberg JP, Nussenzweig RS, Most H, Orton CG. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei II. Effects of radiation on sporozoites. J Parasitol 1968; 54:1175-80.
64. Mueller AK, Labaied M, Kappe SH, Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005; 433:164-7.
65. Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SH. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. PNAS 2005; 102:3022-7.
66. Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, Franetich JF, et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol 2007; 37:1511-9.
67. Alavi Y, Arai M, Mendoza J, Tufet-Bayona M, Sinha R, Fowler R, et al. The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti. Int J Parasitol 2003; 33:933-43.
68. Smith T, Maire N, Ross A, Penny M, Chitnis N, Schapira A, et al. Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology 2008; 135:1507-16.
69. Sinden RE, Dawes EJ, Alavi Y, Waldock J, Finney O, Mendoza J, et al. Progression of Plasmodium berghei through Anopheles stephensi is density-dependent. PLoS Pathogens 2008; 3:195.
70. Dawes EJ, Zhuang S, Sinden RE, Basáñez MG. The temporal dynamics of Plasmodium density through the sporogonic cycle within Anopheles mosquitoes. Trans R Soc Trop Med Hyg 2009; [Epub ahead of print].
71. Hogg JC, Hurd H. Plasmodium yoelii nigeriensis: the effect of high and low intensity of infection upon the egg production and bloodmeal size of Anopheles stephensi during three gonotrophic cycles. Parasitology 1995; 111:555-62.
72. Hogg JC, Hurd H. The effects of natural Plasmodium falciparum infection on the fecundity and mortality of Anopheles gambiae sl in north east Tanzania. Parasitology 1997; 114:325-31.
73. Rowland M, Boersma E. Changes in the spontaneous flight activity of the mosquito Anopheles stephensi by parasitization with the rodent malaria Plasmodium yoelii. Parasitology 1988; 97:221-7.
74. Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH. Synthetic GPI as a candidate antitoxic vaccine in a model of malaria. Nature 2002; 418:785-9.